Cita APA (7a ed.)

Q, F., C, L., W, G., X, G., & N, D. (2019). Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation. Dove Medical Press.

Cita Chicago Style (17a ed.)

Q, Feng, Liu C, Gao W, Geng X, y Dai N. Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation. Dove Medical Press, 2019.

Cita MLA (8a ed.)

Q, Feng, et al. Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation. Dove Medical Press, 2019.

Precaución: Estas citas no son 100% exactas.